Efficacy and Safety of Intravitreal Brolucizumab in Chronic Central Serous Chorioretinopathy: A Retrospective Cohort Study [Letter]. [PDF]
Clin OphthalmolElsaddig M.
europepmc +1 more source
Choroidal Thickness and brolucizumab intravitreal injection: Cause or effect of intraocular inflammation? [PDF]
Cennamo, Gilda +3 more
core +1 more source
"Real world outcomes of intravitreal brolucizumab for persistent diabetic macular edema". [PDF]
Int J Retina VitreousHansraj S +4 more
europepmc +1 more source
Efficacy and Safety of Intravitreal Brolucizumab in Chronic Central Serous Chorioretinopathy: A Retrospective Cohort Study [Response to Letter]. [PDF]
Clin OphthalmolChakraborty S +3 more
europepmc +1 more source
Predictive factors for the efficacy of brolucizumab in refractory polypoidal choroidal vasculopathy following aflibercept resistance. [PDF]
PLoS OneYoshinaga A +6 more
europepmc +1 more source
Aflibercept high-dose (8mg) related intraocular inflammation (IOI) – a case series [PDF]
Eandi, Chiara
core +1 more source
Efficacy and Safety of Switching from Ranibizumab to Brolucizumab in Age-Related Macular Degeneration: Multicenter Real-World Outcomes. [PDF]
Clin OphthalmolHejsek L +8 more
europepmc +1 more source
Efficacy and Safety of Intravitreal Brolucizumab in Chronic Central Serous Chorioretinopathy: A Retrospective Cohort Study. [PDF]
Clin OphthalmolChakraborty S +3 more
europepmc +1 more source
Efficacy of Intravitreal Brolucizumab for Chronic Central Serous Chorioretinopathy: A Pilot Study. [PDF]
J Pers MedHwang S +4 more
europepmc +1 more source
Twelve-Month Outcomes of Anti-VEGF Therapy for nAMD with Brolucizumab, Aflibercept, and Ranibizumab in the Polish National Registry: A Multicenter Database Study. [PDF]
J Clin MedTeper S +9 more
europepmc +1 more source